The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer

被引：0
|
作者：
Goro Nakayama
Chie Tanaka
Keisuke Uehara
Naoki Mashita
Naomi Hayashi
Daisuke Kobayashi
Mitsuro Kanda
Suguru Yamada
Tsutomu Fujii
Hiroyuki Sugimoto
Masahiko Koike
Shuji Nomoto
Michitaka Fujiwara
Yuich Ando
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] Nagoya University Graduate School of Medicine,Department of Surgical Oncology (Surgery I)
[3] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Colorectal cancer; Relative dose intensity; Dose index; Time index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：847 / 855
页数：8
相关论文
共 50 条
  • [1] The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer
    Nakayama, Goro
    Tanaka, Chie
    Uehara, Keisuke
    Mashita, Naoki
    Hayashi, Naomi
    Kobayashi, Daisuke
    Kanda, Mitsuro
    Yamada, Suguru
    Fujii, Tsutomu
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Ando, Yuich
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 847 - 855
  • [2] The impact of dose reduction and time delay in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer
    Mashita, Naoki
    Nakayama, Goro
    Hayashi, Naomi
    Tanaka, Chie
    Kobayashi, Daisuke
    Kanda, Mitsuro
    Yamada, Suguru
    Fujii, Tsutomu
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Ando, Yuichi
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Bimonthly Chemotherapy with Oxaliplatin, Irinotecan, Infusional 5-Fluorouracil/Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with Irinotecan- or Oxaliplatin-Based Chemotherapy
    Nobili, S.
    Checcacci, D.
    Filippelli, F.
    Del Buono, S.
    Mazzocchi, V.
    Mazzei, T.
    Mini, E.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 622 - 631
  • [4] Comparing Time to Disease Progression of Irinotecan and Oxaliplatin-based Chemotherapies in Colorectal Cancer Patients With Liver Only Metastasis
    Varol, Umut
    Karaca, Burcak
    Cakar, Burcu
    Sezgin, Canfeza
    Karabulut, Bulent
    Uslu, Ruchan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (04): : 388 - 391
  • [5] Mucinous histology in advanced colorectal cancer patients treated with first-line irinotecan- and/or oxaliplatin-based chemotherapy
    Catalano, V.
    D'Emidio, S.
    Loupakis, F.
    Graziano, F.
    Torresi, U.
    Mari, D.
    Bisonni, R.
    Giordani, P.
    Giustini, L.
    Falcone, A.
    Silva, R. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
    Liu, Wei
    Chen, Feng-Lin
    Wang, Kun
    Bao, Quan
    Wang, Hong-Wei
    Jin, Ke-Min
    Xing, Bao-Cai
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (09): : 904 - 917
  • [7] Irinotecan and oxaliplatin-based regimens in metastatic colorectal cancer and optimization of sequence: a regional cancer center study
    Kumari, P.
    Narayan, S.
    Singhal, M.
    Saugat, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 88 - 88
  • [8] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [9] Optimal Sequence of Irinotecan and Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer: A Population-Based Observational Study
    Teng, Chieh-Lin Jerry
    Wang, Chen-Yu
    Chen, Yi-Huei
    Lin, Ching-Heng
    Hwang, Wen-Li
    PLOS ONE, 2015, 10 (08):
  • [10] Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen
    Emami, Hamid
    Shakeri, Ali Asghar
    Akhavan, Ali
    Shahbazi-Gahrouei, Daryoush
    Akbari, Pouya
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
12345